Pharmetheus
Emma Ångström has a diverse work experience in finance and administration. Emma started their career as an Auditor at PwC in 1997 and worked there until 2000. Emma then joined Fresenius Kabi as a Controller and later became a Production Controller. In 2011, they started working at the Medical Products Agency Läkemedelsverket, where they held various roles including Controller and Acting Financial Manager. In 2016, they joined Pharmetheus as the Finance and Administration Manager and later became the CFO in April 2019.
Emma Ångström attended Uppsala University from 1992 to 1996. Emma obtained their Executive Master of Finance certification from Chefakademin in 2023 and their Certifikat Rätt fokus i styrelsearbetet from StyrelseAkademien in 2020.
This person is not in any offices
Pharmetheus
We are a consultancy firm offering services focused on the application of quantitative approaches to support drug research, development, and life-cycle decisions with the overall aim to improve patients’ lives. Our story began in 2012, when a team composed of experienced consultants, leaders from the pharmaceutical industry and researchers from Uppsala University formed Pharmetheus, Since then, our core business focus has broadened to support a wider range of model informed drug development (MIDD) activities across all phases of research and development and across a wide range of therapeutic areas. We continue to provide fit for purpose analyses and reports to support a wide variety of drug development decisions (such as dose selection, developing pediatric development plans, investigating the potential risk for QTc prolongation etc.). Read more at www.pharmetheus.com